Millions of Medicare Recipients Could Gain Access to Weight-Loss Drug

Tens of millions of obese or overweight sufferers with coronary heart situations insured beneath Medicare might achieve entry to a preferred weight-loss drug, a examine has discovered. Novo Nordisk’s Wegovy, chemically referred to as semaglutide, was accepted by the U.S. Meals and Drug Administration final month for reducing the danger of stroke and coronary heart...